
Tata group to launch India's first low cost Covid-19 test 'Feluda'
DCGI has approved India's first CRISPR Covid-19 test developed by the Tata Group and CSIR-IGIB.Tata group has worked closely with CSIR-IGIB and ICMR to create a high-quality Covid-19 test
"The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests, with quicker turnaround time, less expensive equipment, and better ease of use. Moreover, CRISPR is a futuristic technology that can also be configured for the detection of multiple other pathogens in the future,' it said.